Skip to content

Dermal and Gynecological Acceptability (Irritability and Sensitization in the Genital Mucosa) of an Investigational Product and Evaluation of Moisture Efficacy by TEWL and Perceived Efficacy.

Dermal and Gynecological Acceptability (Irritability and Sensitization in the Genital Mucosa) of an Investigational Product and Evaluation of Moisture Efficacy by TEWL and Perceived Efficacy.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03007615
Acronym
DERM GYN ACCEP
Enrollment
33
Registered
2017-01-02
Start date
2017-01-31
Completion date
Unknown
Last updated
2017-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Dry Genital Mucosa

Brief summary

To evaluate the safety of an investigational product through the verification of signs of irritability and sensitization of the genital mucosa, as well as the instrumental moisturizing efficacy by TEWL and barrier integrity analysis, in addition to the efficacy perceived by the volunteers.

Interventions

OTHERIntimate Lubricant Gel

Sponsors

Kley Hertz S/A
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy female sex with active sex life; * Age group: between 45 and 65 years old; * Menopause for at least six months; * Whole skin in the region of product analysis; * No history of reaction to products of the same category * Understanding, agreement and signature of the Term of Free and Informed Consent.

Exclusion criteria

* Gestation or risk of gestation; * Use of anti-inflammatory / immunosuppressive drugs (in the last 30 days and during the study); * Active cutaneous pathologies (local and / or disseminated) in the evaluation area; * Pathologies that cause suppression of immunity, such as diabetes, HIV, etc.; * Endocrine pathologies such as thyroid disorders, ovarian or adrenal gland disorders; * Any infection in the region of analysis of the product diagnosed at the time of inclusion; * Other conditions considered by the investigating physician as reasonable for disqualification of the individual from the study participation.

Design outcomes

Primary

MeasureTime frame
Evaluation of the product's efficiency as a moisturizer through subjective evaluation30 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026